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Background: Bidara is drought tolerant and very easy to grow in tropical cli-
mates such as Indonesia. Bidara contains a combination of calcium, potassium, 
and magnesium, and active flavonoid compounds, and antioxidant activity that 
play a role in inhibiting free radical damage, improving endothelial function so 
that it can potentially lower blood pressure. Previous studies explained that a 
dose variant of no more than 300mg/kg BW is beneficial while minimizing patho-
logical changes. However, there has been no research related to the effect of 
bidara leaf in lowering blood pressure, so it is necessary to do related research. 
Objective: Analyze the effect of bidara leaf extract at a 200 mg/kg BW dose and 
300 mg/kg BW on systolic and diastolic blood pressure. 
Methods: 24 pregnant female Wistar rats induced hypertension, aged 6-8 
weeks with a weight of 130-230 grams. The rats were randomized so that they 
consisted of 2 control groups and two experimental groups, which were given 
various doses of bidara leaf for nine days. Blood pressure was measured using 
non-invasive CODA. 
Results: The blood pressure of rats in the bidara leaf extract group at doses of 
200mg/kg BW and 300mg/kg BW decreased systolic and diastolic compared to 
the control group (p<0.05). The 200mg/kg BW dose group experienced a de-
crease in blood pressure of 12.3% for systolic and 16.32% for diastolic; the 
300mg/kg BW dose group experienced a decrease in blood pressure of 19.99% 
for systolic and 27.73% for diastolic. 
Conclusion: Bidara leaf extract can reduce the blood pressure of pregnant rats 
with hypertension. 
KEYWORDS 







Hypertension significantly contributes to the high maternal 
mortality rate. World Health Organization estimates that 
the maternal mortality rate in the world due to hypertension 
is 14%.1 The pathophysiology of hypertension in pregnant 
women is associated with the spiral artery vascular remod-
eling process's failure to trigger vasoconstriction that inhib-
its uteroplacental blood flow, resulting in placental hypoxia 
and ischemia. Placental hypoxia and ischemia can cause 
an increase in the formation of free radicals that trigger ox-
idative stress resulting in endothelial dysfunction that can 
interfere with nitric oxide production and become a clinical 
manifestation of preeclampsia.2 
 
The combination of macrominerals such as calcium, mag-
nesium, and potassium and the presence of flavonoids are 
considered to lower blood pressure by increasing serum 
nitric oxide in endothelial cells and reducing contractility in 
smooth muscle so that it can inhibit vasoconstriction.3–6 
Medicinal plants that have previously been shown to lower 
blood pressure are bay leaf and celery leaf, which contain 
macrominerals that influence blood pressure. The macro-
mineral content in bay leaf on 100grams is 834mg calcium, 
120mg magnesium, and 529mg potassium, while celery 
leaf contains 40mg calcium, 11mg magnesium, and 
260mg potassium.7,8 Bay leaf water decoction can reduce 
blood pressure by 6.77% for systolic and 3% for diastolic 
4, while the ethanol extract of celery can reduce systolic 
blood pressure by 5.7% and diastolic by 5.95%.3 Although 
it can lower blood pressure, previous preclinical studies 
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have stated that celery leaf cannot be recommended as an 
antihypertensive during pregnancy because it is thought to 
have the exact mechanism as captopril, so there is a risk 
of causing fetal weight loss.9 
 
Bidara leaf contains more potassium (673mg%), calcium 
(1270mg%), magnesium (169mg%) than celery and bay 
leaf,10 in addition, there are active flavonoid compounds 
(9,6±1,2mg QE/g DW)11 and potent antioxidant activity 
with IC50 90.9584 ppm.12 Previous studies have examined 
the toxicity test on bidara leaf extract and found that a dose 
of 300mg/kg BW was beneficial because it could prevent 
and minimize the pathological changes caused by mercury 
in the kidneys.11 Bidara leaf extract at a dose of 600mg/kg 
BW had a toxic risk to the liver, characterized by changes 
in the histopathological structure of liver cells.13 Bidara leaf 
has various benefits when used with the correct dose, so 
that in its application as a non-pharmacological treatment. 
People in Lorestan Province have used bidara leaf as a 
medicinal plant to control high blood pressure.14 
 
However, strong evidence still needs to state that bidara 
leaf functions as a safe and effective antihypertensive for 
consumption. The accuracy of the research results was 
assessed through monitoring for side effects and toxicity. 
The community at large has used non-pharmacological 
treatments that utilize herbs. However, animal testing 
needs a solid preclinical basis for dosage and quality en-
forcement before conducting large-scale clinical trials in 
humans.14,15 Rats were used as research subjects be-
cause they have several advantages, like being easy to 
handle.16 This study aims to prove the effectiveness of var-
ious doses of bidara leaf extract on lowering blood pres-
sure in pregnant rats with hypertension. 
METHOD 
Study Design 
This is an experimental study using animals with a ran-
domized pretest-posttest control group design. 
Study Site 
This research was carried out in three different university 
laboratories in Semarang, namely the manufacture of ex-
tracts at the Food Technology Laboratory of Diponegoro 
University, the manufacture of a pregnant rat model as well 
as hypertension induction at the Biology Laboratory of the 
State University of Semarang, and the administration of 
extracts as well as blood pressure measurements were 
carried out in the pharmacology laboratory of Wahid 
Hasyim University. 
Materials 
The surgical instruments used in this study were: medical 
gloves, surgical scissors, anatomical tweezers, Petri dish 
glass, stainless-bottom wax surgical board, closed con-
tainer, caliper, and millimeter block paper. The other tools 
include a rat cage, non-invasive CODA® instrument set, 
trays, scissors, labels, markers, syringes, measuring flask 
tubes, oral probes, and digital scales. The main ingredi-
ents used in this research are bidara leaf extract (Ziziphus 
spina-christi), aqua dest, 96% ethanol, NaCl, and dexame-
thasone for hypertension induction. Materials used in the 
operation of pregnant rats, namely: NaCl and chloroform. 
Plant Extraction 
The bidara leaf is mashed first using a blender so that they 
become dry bidara leaf powder. The dried bidara leaf pow-
der was macerated with 96% ethanol solvent for ±3x24 
hours, accompanied by occasional stirring. When the pro-
cess has been completed, it continues with filtering. How-
ever, the residue is macerated again with 5L ethanol so 
that the maceration is carried out two times within ±2x24 
hours, and proceed with the filtration process. The last 
stage is evaporation to remove the solvent so that only the 
compound or leaf extract is left by using a rotary evapora-
tor at a temperature of 45-50oC to produce extracts in the 
form of thick or paste dosage forms.13 
In Vivo Procedure 
Animal Preparation  
The experimental animal used in this study was a white 
female rat Wistar strain. Rats were acclimatized for seven 
days, equipped with cages with wood husks, with a room 
temperature of 25-26oC and 76-87% humidity. 
 
Making Pregnant Rats 
The process of making pregnant rats is carried out when 
female rats are in estrus. Initial management is to equalize 
the estrus period of female rats and use the pheromone 
method for three days by placing female rats in a typical 
cage with smell or urine previously occupied by male rats. 
On the third day of implementing the pheromone method, 
mating was carried out in the afternoon until the next day, 
sperm cells were found in the vaginal smear on micro-
scopic examination. That day was declared as the first day 
of pregnancy.17 
 
Making Rats with Hypertension Model 
The research sample that had been determined was di-
vided into an intervention group and a control group with-
out intervention. The control group without intervention 
was a group of pregnant rats without being induced to 
have hypertension. In contrast, the intervention group was 
a group of hypertensive rats induced by dexamethasone 
0.018mg given three times a day and 3ml of 8% NaCl a 
day given orally for seven days starting from day one until 
the 7th day of pregnancy to experience an increase in 
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Experimental Procedure 
Twenty-four rats that were declared pregnant based on mi-
croscopic examination were divided into three groups with 
induced hypertension using dexamethasone and NaCl, 
while 1 group without induced hypertension, namely six 
rats for the bidara leaf extract group at a dose of 200mg/kg 
BW, six rats for the bidara leaf extract group at a dose of 
300mg/kg BW, six rats in the positive control group that 
only induced hypertension, and six rats in the negative 
control group without hypertension-induced and extract 
administration. Both experimental groups were given bi-
dara leaf extract once a day for nine days with different 
doses of 200mg/kg BW and 300mg/kg BW. 
The Variable, Instrument, and Measurement 
The dependent variable in this study was systolic and di-
astolic blood pressure which was measured using a non-
invasive CODA instrument. Measurements were carried 
out without anesthesia and only using the tail-cuff auto-
pickup method, which was placed in the rat's tail to monitor 
blood pressure equipped with a Volume Pressure Re-
corder sensor. When administering blood pressure meas-
urements, it should be noted that during the examination, 
the rats are placed on a warmer or heating board so that 
blood pressure can be measured accurately as well as its 
constituents by the VPR system.20 
Statistical Analysis 
Data analyzed with Manova test with a significant level at 
p <0.05. 
Ethical Consideration 
This research has been registered with the Research Bio-
ethics Commission of Sultan Agung Islamic University Se-
marang with the Ethical Clearance number 8/1/2021/Bio-
ethics Commission. 
RESULTS 
Experiment dose 200mg/kg BW experienced a 12.3% de-
crease in systolic and 16.15% diastolic, while the Experi-
ment dose 300mg/kg BW decreased systolic by 20% and 
diastolic by 27.73%. The decrease in systolic blood pres-
sure experienced by the two experimental and control 
groups at the time of measurement is shown in Figure 1, 
and diastolic blood pressure is shown in Figure 2. Both ex-
perimental groups experienced a significant decrease in 
blood pressure on the 6th day for the experiment 
300mg/kg BW dose group and on the 9th day for the ex-
periment 200mg/kg BW dose group (p<0.05). 
 
The effect of bidara leaf extract on reducing blood pres-
sure in pregnant rats with hypertension was indicated by a 
decrease in systolic and diastolic in the experimental 
group and the difference in the value of the difference in 
decline between the experimental group and the control 
group. After rats were induced with hypertension using 
NaCl and dexamethasone, the systolic and diastolic val-
ues were higher than average blood pressure values. The 
mean value of the difference in blood pressure reduction 
between groups is shown in Table 1, which significantly 
differs between the two experimental groups and the two 
control groups (p<0.05). 
 









Systolic Experiment dose 
200mg/kg BW 
Experiment dose 300mg/kg 
BW 
16.67 29.17 -12.500 0.136 
0.603 
Positive control  16.67 -3.8 20.467 0.025 
Negative control 16.67 -15.17 31.833 0.001 
Experiment dose 
300mg/kg BW 
Positive control  29.17 -3.8 32.967 0.001 
Negative control 29.17 -15.17 44.333 0.00001 
Positive control  Negative control -3.8 -15.17 11.367 0.193 
Negative control Experiment dose 200mg/kg 
BW 
-15.17 16.67 -31.833 0.001 
Experiment dose 300mg/kg 
BW 
-15.17 29.17 -44.333 0.00001 
Positive control -15.17 -3.8 -11.367 0.193 
        
Diastolic Experiment dose 
200mg/kg BW 
Experiment 300mg/kg BW 15.83 30 -14.167 0.160 
0.457 
Positive control  15.83 -10.6 26.433 0.017 
Negative control 15.83 -5.17 21.000 0.043 
Experiment dose 
300mg/kg BW 
Positive control  30 -10.6 40.600 0.001 
 Negative control 30 -5.17 35.167 0.002 
Positive control  
Negative control 
Negative control -10.6 -5.17 -5.433 0.599 
Experiment 200mg/kg BW -5.17 15.83 -21.000 0.043 
Experiment 300mg/kg BW -5.17 30 -35.167 0.002 
Positive control -5.17 -10.6 5.433 0.599 
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Figure 1. Changes in Mean Systolic Blood Pressure Figure 2. Changes in Mean Diastolic Blood Pressure 
 
DISCUSSION 
This study found the more significant effect of bidara leaf 
extracts on systolic blood pressure than diastolic, due to 
the significant macro minerals such as potassium and 
magnesium. The content of potassium in bidara leaf plays 
a role in controlling cardiac output, which is closely related 
to the cause of changes in systolic, as well as the presence 
of magnesium in bidara leaf, which plays a role in main-
taining heart rhythm so that it remains in normal condition, 
improving blood flow to the heart while providing a seda-
tive effect. However, to reduce diastolic, there is only the 
role of flavonoid active compounds that can affect the work 
of Angiotensin-Converting Enzyme. It triggers vasodila-
tion, which will reduce peripheral decrease diastolic re-
sistance.21 
 
The magnitude of the effect of giving bidara leaf extract 
was also assessed through the finding of a significant in-
teraction between group associations and the period of 
giving the extract with a p-value of 0.0001 for systolic and 
0.006 for diastolic so that it can be interpreted that bidara 
leaf extract was given in various doses with the time of ad-
ministration. The various extracts, namely the 3rd day, the 
sixth day, and the ninth day simultaneously (together), 
contributed to the decrease in blood pressure. 
 
Hypertension consists of various classifications. A systolic 
blood pressure of 130-139mmHg or a diastolic of 80-
89mmHg has been included as the first hypertension 
stage. The blood pressure has increased with a systolic 
value of 140mmHg, or a diastolic 90mmHg has been in-
cluded as a second stage hypertension.22 Hypertension is 
caused by many factors and is complex due to neurohor-
monal factors. Oxidative stress plays an essential role in 
the pathophysiology of hypertension. It causes endothelial 
dysfunction that affects reduced nitric oxide levels, thereby 
inhibiting the endothelial relaxation process and resulting 
in hypertension.2–5 Oxidative stress is defined as an imbal-
ance between the production of free radicals and the inef-
fective use of antioxidants in the body, thus triggering cell 
damage that results in diseases, including hypertension. 
The severity of endothelial damage due to excessive oxi-
dative stress will affect lower nitric oxide production so that 
it interferes with vasodilation which results in severe hy-
pertension.23  
 
In this study, the experimental group given bidara leaf ex-
tract also experienced a decrease in blood pressure. Ex-
periment 200mg/kg BW had a decrease in systolic blood 
pressure of 12.3% (16.67mmHg) and a decrease in dias-
tolic blood pressure of 16.32% (15.83mmHg). Experiment 
300mg/kg BW had a percentage decrease in systolic blood 
pressure reaching 19.99% (29.17mmHg), and 27.73% 
(30mmHg) for diastolic. Other than that, the experimental 
group did not have a difference in blood pressure reduction 
on the sixth and ninth days during the consumption period 
of bidara leaf extract. However, the treatment was contin-
ued until the ninth day to decrease blood pressure until it 
reached the normal classification. The experimental group 
which was included as the hypertension induction group 
experienced a decrease in blood pressure because bidara 
leaf with varying doses, namely experiment 200mg/kg BW 
and experiment 300mg/kg BW, had more macromineral 
content such as potassium (673mg%), calcium 
(1270mg%), and magnesium (169 mg%) as well as flavo-
noid bioactive compounds (9.6±1.2mgQE/g DW) which 
play an important role in controlling blood pressure. Bidara 
leaf also has antioxidant activity with an IC50 value of 23.4 
ppm, categorized as having robust activity.10–12  
 
The content contained in the bidara leaf has its respective 
role in lowering blood pressure. The macro-mineral con-
tent is thought to lower blood pressure through vasodila-
tion which causes a decrease in total peripheral retention 
and increases cardiac output. Adequate calcium intake 
can affect the concentration of extracellular calcium, which 
plays a vital role in endothelium synthesis to repair physi-
ological damage caused by oxidative stress. In addition to 
calcium, magnesium also increases nitric oxide and im-
proves endothelial function.24,25 Potassium which is in 
charge of changing the activity of renin-angiotensin and 
together with calcium, can affect the level of smooth mus-
cle contraction so that vasodilation occurs and results in a 
decrease in blood pressure; magnesium and flavonoids, 
which act as ACE inhibitors and antioxidants which are 
tasked with suppressing oxidative stress thereby reducing 
continuous damage to the endothelium as well resulting in 
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increased nitric oxide synthesis which acts as a potent 
vasodilator in relaxing blood vessels and lowering blood 
pressure, besides that the fulfillment of potassium, cal-
cium, and magnesium can also suppress sodium concen-
trations in overcoming mineral imbalances so that it can 
affect arterial pressure. 
 
The experimental and positive control groups were preg-
nant rats induced by hypertension using dexamethasone 
to decrease nitric oxide production while disrupting endo-
thelial cell function and causing an increase in blood pres-
sure while inhibiting intrauterine fetal growth. Compared 
with the positive control group, the experimental group was 
known to have significant differences because the experi-
mental group was given treatment using bidara leaf ex-
tract, in contrast to the positive control group, which after 
induced hypertension but was not given treatment so that 
they had unstable blood pressure. This underlies why 
there is no significant difference in blood pressure values 
between experiment 200mg/kg BW and experiment 
300mg/kg BW. Both doses could reduce blood pressure 
until it reached the standard blood pressure classification. 
Researchers reviewed in terms of the time of administra-
tion, and it was found that the bidara leaf extract at a dose 
of 300mg/kg BW could significantly reduce blood pressure 
on day 6, in contrast, to experiment 200mg/kg BW which 
experienced a significant decrease in blood pressure on 
day 9. 
 
The results of this study are in line with research con-
ducted that assessed that the active flavonoid content in 
the leaf of the Ziziphus mauritiana given was considered 
to prevent an increase in blood pressure and improve glo-
merulosclerosis that occurs due to hypertension.26 This 
study is also in line with the other research that showed 
that Ziziphus spina-christi extract has an anxiolytic activity 
that can treat anxiety disorders associated with oxidative 
stress modulation. It can also affect serum malondialde-
hyde levels.27 The difference between this study and pre-
vious research related to bidara leaf is that the research 
subject is devoted to being pregnant, affecting the duration 
of hypertension induction and extract administration. In 
contrast, previous studies were male rats with 28 days of 
extract administration. No research on bidara (Ziziphus 
spina-christi) explicitly discusses its effect on systolic and 
diastolic blood pressure.  
 
Negative control group rats in this study that were not in-
duced by hypertension and were not given extracts tended 
to be more challenging to adapt to the CODA space so that 
even though they had been given time to adapt, they still 
had unstable blood pressure due to modulation of oxida-
tive stress during pregnancy, in contrast to rat in the group 
experiments that tend to be calmer and do not fight, which 
is thought to be due to the bidara leaf extract that is given 
besides affecting blood pressure also has an anxiolytic ac-
tivity that can treat other variables such as anxiety disor-
ders experienced by rats. 
 
This study did not examine teratogenicity by assessing the 
number of fetuses and fetal weight. At the time of surgery, 
the rats found that not all 24 rats had developing fetuses, 
and many of them had stunted growth and were suspected 
of having implantation failure. Previous studies have 
stated that there is a 70% chance of embryo failure to im-
plant or implantation failure, which clinically even though 
the results of a pregnancy test through the examination of 
human chorionic gonadotropin (HCG) in the urine are pos-
itive, but the process can fail before the formation of the 
intrauterine gestational sac.28 Different studies also as-
sessed that implantation success in rats occurred in a 
short period starting from day 4 to day 6 of pregnancy, 
marked by points suspected as implantation sites.29 
 
One of the causes of disruption of the pregnancy process 
and fetal growth inhibition in this study was the induction 
of hypertension through the administration of dexame-
thasone. Dexamethasone causes an increase in nitric ox-
ide synthase trafficking inducer (NOSTRIN) protein to 
weaken nitric oxide production, which is found in the pla-
centa of women with preeclampsia and gestational hyper-
tension. Thus, affecting endothelial cell function and caus-
ing intrauterine growth restriction.18 
CONCLUSIONS AND RECOMMENDATION 
Bidara leaf extract can reduce blood pressure in various 
doses, especially the dose of 300mg/kg BW, which has 
decreased significantly on the sixth day. Researchers sug-
gest that this study can further research, such as histo-
pathological tests on the uterus. 
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